Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Recovery article

BPC-157 Injection Burn: Why It Happens & How to Prevent It

It’s a question our team hears all the time. You’ve done the reading, you understand the potential, and you’re ready to begin your research with BPC-157. But then you stumble upon forum posts or anecdotal reports mentioning a sharp, stinging, or burning sensat

It’s a question our team hears all the time. You’ve done the reading, you understand the potential, and you’re ready to begin your research with BPC-157. But then you stumble upon forum posts or anecdotal reports mentioning a sharp, stinging, or burning sensation at the injection site. Suddenly, a bit of hesitation creeps in. Is this normal? Is it something to be worried about? Does BPC-157 burn when injected?

Let’s cut right to the chase: while a mild, fleeting sting can happen, a significant, painful burn is not a standard part of the process. It's a signal. It's your body telling you that something isn't quite right. The good news is that the causes are almost always identifiable and, more importantly, preventable. We've spent years immersed in the world of high-purity peptide synthesis, and we’ve seen firsthand what separates a smooth, uneventful research application from a needlessly uncomfortable one. This isn't just about managing a minor annoyance; it's about understanding the critical factors that influence the quality and integrity of your research from the very first step.

The Short Answer: Yes, It Can, But It Shouldn't

So, does BPC-157 burn? Sometimes. But the intensity and frequency of that sensation are what really matter. A tiny prickle or a faint sting that vanishes in seconds is one thing. A throbbing, persistent burn that leaves the area red and sore for an extended period is something else entirely. That’s a red flag.

Our experience shows that this discomfort is rarely caused by the BPC-157 molecule itself. Think about it. The peptide is composed of amino acids, the fundamental building blocks of proteins in your body. When synthesized to an exceptional standard of purity—like the BPC-157 Peptide we produce here at Real Peptides—the compound should be well-tolerated. The problem almost always lies with other variables. These are the culprits we need to investigate, from the quality of the product to the specifics of your administration technique.

It's a process of elimination. By understanding each potential factor, you can systematically troubleshoot the issue and ensure your research protocols are not just effective, but also comfortable and consistent. This is foundational to gathering reliable data. If every application feels different, how can you trust your results? You can't. So let's break down the real reasons behind that unwanted burn.

The Prime Suspects: Unmasking the Causes of Injection Burn

When a researcher experiences a burn, their first instinct is often to blame the peptide. That’s understandable, but it's usually misguided. The issue is far more nuanced. We've found that the burn typically originates from one of four areas: product purity, the reconstitution liquid, pH imbalance, or administration technique. Let's be honest, this is crucial.

1. Product Purity (or Lack Thereof)This is the big one. We can't stress this enough: the single most common cause of significant injection site pain is substandard peptide quality. The world of peptides is, unfortunately, filled with providers cutting corners to lower costs. This results in products riddled with impurities that can cause a cascade of inflammatory reactions.

What are these impurities? They can be anything from residual solvents used during synthesis (like acetonitrile or TFA), to improperly formed peptide chains, or other chemical byproducts that were never filtered out during the final purification stages. When you inject a solution containing these contaminants, your body's immune system immediately recognizes them as foreign, hostile invaders. The result? An inflammatory response. Your body sends immune cells to the area to investigate and neutralize the threat, which manifests as redness, swelling, and that distinct burning sensation. It's your body doing its job, but it's a reaction to a problem that shouldn't exist in the first place.

Here at Real Peptides, our entire philosophy is built around preventing this. Our small-batch synthesis and meticulous purification processes are designed to yield a product with impeccable purity, ensuring the lyophilized powder you receive is just the peptide and nothing else. This commitment to an unadulterated final product is the first and most critical line of defense against injection site pain.

2. The Reconstitution LiquidWhat you mix your peptide with matters just as much as the peptide itself. For most research applications, the standard is Bacteriostatic Water. This is sterile water containing 0.9% benzyl alcohol, which acts as a preservative, preventing bacterial growth after the vial has been punctured. While essential for multi-use vials, benzyl alcohol itself can be an irritant for some individuals. Most people don't notice it at all, but those with a sensitivity might experience a mild, sharp sting upon injection. This is typically very brief and distinct from the deep, lingering burn caused by impurities.

If you suspect the bacteriostatic water is the issue, one troubleshooting step could be to try reconstituting with sterile water for injection instead. However, and this is a major caveat, sterile water contains no preservative. This means the vial is strictly for single use and must be handled with extreme aseptic technique to prevent contamination. For most researchers, the safety and convenience of bacteriostatic water far outweigh the potential for a minor, fleeting sting.

3. Incorrect pH BalanceThis is a more technical, but equally critical, factor. Your body maintains a very tightly controlled pH level, typically around 7.4. When you introduce a substance that is significantly more acidic or alkaline, it creates a chemical burn at a microscopic level, triggering pain receptors. A properly manufactured peptide should be lyophilized and reconstituted to a solution that is close to this physiological pH.

If a manufacturer's quality control is sloppy, the final product could have a pH that's way off. This forces your body to work overtime to neutralize the solution, causing immediate and often intense burning. It's another issue that comes directly back to the integrity of the supplier. A company obsessed with quality, like ours, understands the importance of pH balancing for both peptide stability and research subject comfort. It's a non-negotiable part of the production process.

4. Administration TechniqueEven with a perfect product, the way you administer it can make a world of difference. This is the variable you have the most direct control over.

Injection Speed: Injecting the fluid too quickly is a classic mistake. It forces the tissue to expand rapidly, which can damage cells and trigger pain signals. The injection should be slow and steady, allowing the solution to disperse gently into the subcutaneous space.

Volume: Trying to inject too much liquid into one small area can cause similar issues. If your protocol requires a larger volume, it's better to split it into two separate, smaller injections at different sites.

Needle Gauge: Using a needle that is too large (a lower gauge number) can cause unnecessary tissue trauma. For subcutaneous injections, a very fine needle (e.g., 29-31 gauge) is typically all that's needed.

Injection Depth: For BPC-157, subcutaneous injection (into the fat layer just under the skin) is standard. If the needle goes too deep and hits muscle (an intramuscular injection), it can be more painful, and the dispersal characteristics of the peptide change.

Site Rotation: Repeatedly using the exact same injection spot can lead to the buildup of scar tissue and increased sensitivity over time. It's vital to rotate sites to give the tissue time to recover.

Quality Is Not Optional—It Is the Foundation

We've touched on it throughout, but it deserves its own spotlight. In the realm of peptide research, quality is everything. It's the difference between clear, repeatable data and questionable, inconsistent results. It's the difference between a smooth protocol and one plagued by side effects like burning and inflammation. When you choose a supplier, you're not just buying a vial of powder; you're investing in their process, their standards, and their commitment to excellence.

Think of it this way: a chef creating a world-class meal wouldn't start with subpar ingredients. It wouldn't matter how skilled they were—the final dish would be compromised. The same principle applies with unrelenting force to scientific research. Starting with a peptide of questionable origin is like building a house on a cracked foundation. The entire structure is at risk.

Our obsession with quality at Real Peptides is why we focus on small-batch synthesis. It allows for a level of control and precision that's simply impossible in mass production. Every single batch is subjected to rigorous testing to verify its sequence, purity, and concentration. This unflinching dedication ensures that the BPC-157 Peptide you use for your research is exactly what it's supposed to be, free from the contaminants and inconsistencies that cause problems. This isn't just a marketing claim; it's the core principle that allows researchers who use our products to proceed with confidence.

Top 10 Peptides RANKED for MAXIMUM Performance

This video provides valuable insights into does bpc 157 burn when injected, covering key concepts and practical tips that complement the information in this guide. The visual demonstration helps clarify complex topics and gives you a real-world perspective on implementation.

Comparison of Common Causes for Injection Discomfort

To make it even clearer, our team put together a table to help you quickly diagnose what might be going on. This is a practical tool for troubleshooting.

Peptide Purity

High levels of synthesis byproducts, residual solvents (TFA), or incorrect peptide sequences cause a strong inflammatory response.

This is the most likely culprit for severe burning. Start with a product guaranteed for purity. Our rigorous third-party testing verifies that our peptides are free from these contaminants.

Reconstitution

Benzyl alcohol in bacteriostatic water can be a mild irritant for sensitive individuals, causing a brief, sharp sting.

Ensure you are using high-quality, sterile Bacteriostatic Water. If sensitivity persists, consider single-use applications with sterile water, maintaining strict aseptic technique.

pH Level

The reconstituted solution is too acidic or alkaline compared to the body's natural pH (~7.4), causing a chemical irritation.

This is a manufacturing quality control issue. Our synthesis and lyophilization processes are pH-controlled to ensure the final product is biocompatible and minimizes irritation.

Injection Technique

Injecting too fast, using too much volume in one spot, or using a needle that is too large can cause mechanical tissue trauma and pain.

Use a fine gauge insulin syringe (29-31g). Inject slowly and steadily into a pinched fold of subcutaneous fat. Rotate injection sites daily to allow tissue to recover.

A Practical Guide to a Pain-Free Injection

Knowledge is power. Now that you understand the 'why,' let's focus on the 'how.' Here is a straightforward, step-by-step approach our team recommends for minimizing any potential discomfort and ensuring a professional, consistent research application every single time.

Start with an Impeccable Product: This is step zero. You cannot fix a bad product with good technique. Ensure your peptide is sourced from a reputable supplier like Real Peptides that provides documentation of its purity.

Practice Aseptic Reconstitution: Always wipe the tops of both your peptide vial and your bacteriostatic water vial with an alcohol swab before piercing them. Use a new, sterile syringe to draw the water and inject it slowly into the peptide vial, aiming the stream against the side of the glass to avoid damaging the delicate peptide structure.

Gentle Mixing: Don't shake the vial. Ever. This can destroy the peptide chains. Instead, gently swirl or roll the vial between your hands until all the powder is dissolved. The solution should be perfectly clear.

Select and Clean the Site: The most common site for subcutaneous injection is the abdomen, at least two inches away from the navel. The love handles or thigh are also good options. Clean the chosen area thoroughly with a fresh alcohol swab and let it air dry completely.

Pinch the Skin: Gently pinch a one-to-two-inch fold of skin and fat between your thumb and forefinger. This lifts the fatty tissue away from the underlying muscle.

Inject at the Correct Angle: Insert the needle at a 45 to 90-degree angle to the skin surface. The angle depends on how much fatty tissue you have; for most, 90 degrees is fine.

Administer Slowly: This is key. Depress the plunger in a slow, controlled motion. Take five to ten seconds to inject the full volume. This gives the tissue time to accommodate the fluid.

Withdraw and Dispose: Remove the needle swiftly and safely dispose of the syringe in a designated sharps container.

A little bit of mindfulness during this process can make a world of difference. It's not complex, but it demands precision.

When to Be Concerned: Identifying Red Flags

While a mild sting or a tiny red dot at the injection site is generally nothing to worry about, it's vital to know the signs of a more serious issue. A significant burn that doesn't subside is one, but there are others. Be vigilant for:

Excessive Swelling: A small lump (a 'pip') that dissipates within a few hours is common. Swelling that is large, hard, hot to the touch, or continues to expand is not.

Spreading Redness: A small red spot is normal. A red area that grows in diameter or shows red streaks moving away from the site is a potential sign of infection (cellulitis).

Intense Pain: Discomfort should be minimal and brief. Severe, throbbing pain is a major red flag.

Signs of Allergic Reaction: While rare, systemic allergic reactions are possible. Symptoms can include hives, rash, itching, difficulty breathing, or swelling of the face, lips, or tongue. This is a medical emergency.

If you experience any of these more severe symptoms, you should discontinue use and consult with a qualified medical professional immediately. Your safety is paramount.

This Is a Universal Principle

The lessons we've discussed here for BPC-157 are not unique to this one peptide. They are universal truths that apply across the board in peptide research. Whether your work involves TB-500, growth hormone secretagogues like CJC-1295/Ipamorelin, or more complex blends like our Wolverine Peptide Stack, the fundamentals remain the same. Purity dictates safety and efficacy. Technique dictates comfort and consistency. Quality is the bedrock upon which all successful research is built.

By internalizing these principles, you move from simply administering a compound to conducting thoughtful, controlled, and professional research. You gain the ability to troubleshoot problems, ensure the integrity of your work, and maximize the potential of these incredible research tools. You can explore our full collection of peptides with the confidence that every single one is held to the same uncompromising standards of quality.

Ultimately, that initial question—"does BPC-157 burn when injected?"—opens the door to a much more important conversation about quality, diligence, and the standards we should all demand from our research compounds. A burning sensation is more than just an inconvenience; it's a data point. It's telling you to look closer, to demand better, and to prioritize purity above all else. When you start with the highest quality product and combine it with meticulous technique, the answer to that question becomes a confident and resounding 'no.' Now you're ready to Get Started Today on the right foot.

Frequently Asked Questions

Yes, a small red dot at the needle insertion point is completely normal and should fade quickly. However, redness that spreads, feels hot, or is accompanied by significant swelling is not normal and should be monitored.

Any mild stinging sensation should dissipate within a few seconds to a minute. A significant burn that lasts for many minutes or hours is a strong indicator of an issue with product purity, pH, or your injection technique.

You can, but it’s critical to understand the trade-offs. Sterile water has no preservative, making the vial strictly single-use to avoid bacterial contamination. The mild sting from the benzyl alcohol in bacteriostatic water is often preferable to the risk of an unpreserved solution.

Generally, yes. Intramuscular injections can be more painful due to the needle passing through more nerve-rich tissue. For BPC-157 research, subcutaneous injection into the fatty layer is the standard and typically more comfortable method.

While true allergies to the peptide itself are exceedingly rare, it’s possible. It’s more likely, however, that a reaction is caused by impurities from a low-quality manufacturing process. Symptoms of a true allergy would include hives, widespread rash, or difficulty breathing.

Icing the area for a few minutes before injecting can help numb the skin and may reduce the initial prick of the needle. It can also help constrict blood vessels, potentially reducing bruising, but it may not significantly affect a burn caused by purity or pH issues.

It can. Some areas have more nerve endings than others. The subcutaneous fat of the abdomen is generally a well-tolerated spot. Injecting too close to a nerve or into muscle can definitely increase discomfort.

Trifluoroacetic acid (TFA) is a salt often used during the peptide synthesis and purification process. If not properly removed, residual TFA in the final product can lower the solution’s pH, making it more acidic and causing a significant burning sensation upon injection.

Absolutely. Needles are designed for single use. Reusing a needle dulls the tip, causing it to tear tissue rather than pierce it cleanly. This causes more trauma and pain at the injection site.

Injecting slowly allows the fluid to disperse into the subcutaneous tissue gently. Pushing the plunger too fast forces the tissue to expand rapidly, which can damage cells and trigger pain receptors, leading to a burning or aching sensation.

Yes, it’s common to have a small, temporary lump (often called a ‘pip’) at the injection site. This is just the solution sitting in the subcutaneous tissue before it’s fully absorbed. It should dissipate within a few hours and is not a cause for concern unless it’s painful, hot, or grows larger.

CONNECTED / MODULES

Post-session references

Selected from shared article topics. Source links are retained where available.

01

Handling & safety lane

Source-derived education, not individual medical guidance or an instruction to dose.

DOSAGE SOURCE

What Preclinical Studies Actually Show About Efficacy and Dosing

The most cited BPC-157 studied ulcerative colitis research comes from a series of experiments conducted between 2001 and 2017 using three primary colitis induction models: TNBS (trinitrobenzene sulfonic acid), acetic acid, and cysteamine. TNBS models produce transmural inflammation resembling Crohn's disease more than ulcerative colitis, but they're still used for colitis research because they create reproducible mucosal damage. Acetic acid models create superficial mucosal ulceration more similar to ulcerative colitis pathology. Cysteamine models induce duodenal ulcers but have been used to study BPC-157's broader GI healing properties. Across these models, effective doses ranged from 10 nanograms per kilogram to 10 micrograms per kilogram, administered intraperitoneally (injected into the abdominal cavity) or orally. The therapeutic window appears broad. Doses differing by three orders of magnitude showed similar healing effects in some studies, suggesting either high potency or a plateau effect where additional peptide doesn't accelerate healing further. Treatment duration in most studies was 7–14 days, with histological improvements visible as early as day three and maximal healing by day 14. One particularly detailed study published in 2016 compared BPC-157 to sulfasalazine (a standard ulcerative colitis medication) in acetic acid colitis rats. BPC-157 at 10 micrograms per kilogram produced comparable macroscopic healing scores to sulfasalazine 200 milligrams per kilogr…
SIDE EFFECTS

Risks & Side Effects

Because BPC-157 is not FDA-approved and lacks large human safety trials, its full safety profile is unknown. Potential risks may include: Injection-site reactions Local irritation Headache Nausea Dizziness Fatigue Allergic or hypersensitivity reactions Immune reaction to peptide impurities or aggregation Infection risk with injectable products Unknown long-term safety Unknown effects on abnormal tissue growth Theoretical concern in patients with active malignancy due to possible angiogenic and tissue-growth signaling effects The FDA has stated that compounded drugs containing BPC-157 may present safety concerns and that available information is insufficient to determine whether the drug would cause harm when administered to humans.
02

Question drills

Open a question for its connected answer.

01What If The Burning Persists? When to Re-evaluate+

So you've followed every step. You’re using our unimpeachably pure BPC 157 Peptide, you've reconstituted with pristine Bacteriostatic Water, and your technique would make a clinician proud. But you're still feeling a burn. What now? First, don't panic. While rare, it's time for more advanced troubleshooting. Start by trying a different injection location. Some areas of the body are simply more sensitive than others. An injection in the thigh might feel different from one in the abdomen. Experiment and see if the sensation changes. Second, consider the possibility of a sensitivity to the benzyl alcohol in the BAC water. This is exceedingly uncommon, but not impossible. In such a specific research scenario, one might consider reconstituting with sterile water for single, immediate use only—discarding any remainder to avoid the certainty of bacterial contamination. This is an advanced technique and requires an uncompromising commitment to sterility. Finally, listen to the data your body is providing. If you develop a persistent rash, welts, or significant, painful swelling that doesn't subside, the correct course of action is to halt the protocol. These are signs of a more serious inflammatory or allergic reaction that should not be ignored. The goal of research is to gather data safely and effectively, and pushing through a clear adverse reaction is counterproductive to that mission. This is where exploring our full range of All Peptides might offer alternative compounds for your research goals. Ultimately, the sensation of burning during a BPC 157 injection is not the norm; it's an exception that points to a solvable problem. By controlling for quality, technique, and supplies, you can transform it from a frustrating variable into a non-issue. Precision in your process, from sourcing to administration, is what separates ambiguous results from breakthrough discoveries. We encourage you to adopt this meticulous approach and see the difference it makes. When you're ready to ensure the quality of your materials, we're here to help you Get Started Today.

SOURCE / realpeptides.co ↗
02What If BPC-157 Is Administered After Barrier Damage Has Already Occurred?+

Administer BPC-157 as soon as damage is identified. Preclinical data shows reparative effects even when the peptide is introduced post-injury. In NSAID-induced enteropathy models, BPC-157 given after indomethacin exposure still reduced lesion formation by 80%, indicating the peptide doesn't require pre-treatment to exert protective effects. The VEGF-driven angiogenesis and tight junction protein upregulation mechanisms remain active regardless of timing, though earlier administration likely shortens recovery duration.

SOURCE / realpeptides.co ↗
03What If I'm Taking NSAIDs Long-Term — Can BPC-157 Prevent Further Damage?+

NSAIDs cause intestinal permeability by inhibiting COX enzymes, which reduces prostaglandin production and weakens mucosal defences. BPC-157 doesn't block COX inhibition but it counteracts the downstream tight junction breakdown: it sustains occludin expression even when prostaglandin levels are suppressed, and it reduces the oxidative stress that NSAIDs generate in enterocytes. Rodent studies show that pre-treatment with BPC-157 before NSAID administration reduces measured permeability by 40–50% compared to NSAID-only controls. Dosing: 10 μg/kg subcutaneously 30 minutes before NSAID intake in animal models. Human extrapolation would be 200–300 μg before each NSAID dose.

SOURCE / realpeptides.co ↗
04What If I Have Diabetic Peripheral Neuropathy — Could BPC-157 Help?+

Consult an endocrinologist before considering any experimental peptide. Diabetic neuropathy develops over years through chronic hyperglycemia-induced oxidative damage. It's not an acute injury like the crush models used in bpc-157 studied neuropathy research. The pathophysiology differs: diabetic nerves face ongoing metabolic stress, not a discrete lesion that can heal. Animal studies showing benefit used streptozotocin-induced diabetes, which mimics Type 1 more than Type 2. No human data exists to guide dosing, duration, or expected outcomes.

SOURCE / realpeptides.co ↗
05What If I'm Using BPC-157 Capsules Instead of Injectable—Do I Still Need Syringes?+

No. BPC-157 Capsules eliminate injection supplies entirely, but understand the bioavailability trade-off: oral BPC-157 undergoes first-pass hepatic metabolism and gastric protease degradation that reduces systemic absorption to 5-15% of the ingested dose compared to 85-95% for subcutaneous injection. Capsules work for localized gastric and intestinal applications where the peptide acts on mucosal tissue before absorption, but they're not equivalent to injection for systemic research applications. If your protocol targets connective tissue repair or systemic anti-inflammatory pathways, injectable BPC-157 with proper syringe supplies remains the evidence-based choice.

SOURCE / realpeptides.co ↗
03

Evidence cooldown

Research context and source excerpts for a slower second read.

RESEARCH

What purity standard should research-grade BPC-157 meet?

Research-grade BPC-157 should be verified at 99%+ purity through HPLC analysis with mass spectrometry identity confirmation and batch-specific Certificates of Analysis, since tissue-repair research endpoints depend on consistent compound quality. All PSPeptides products are sold exclusively for research and laboratory use.

RESEARCH

BPC-157: what scientific studies reveal about its effects

BPC-157 is derived from a protective protein found in the stomach but is considered "synthetic" since this peptide does not exist by itself in nature. It’s touted for a wide variety of reasons and talked about for both nootropic (brain boosting) and ergogenic (performance enhancing) purposes. And based on all the studies published so far, BPC-157 is a surprisingly good regenerative agent. What is BPC-157 thought to aid? Joint Health and Rejuvenation Fibroblasts are a specialized type of cell found in connective tissues. These cells are involved in the creation of collagen. The use of BPC-157 is thought to speed up the growth and spread of fibroblasts and to increase rates of oxidative resistance. In addition to its effects upon fibroblast production. It also affects F-actin formation (which is involved in the spreading of fibroblasts). The peptide has also been successfully used to increase the rate of collagen reformation following surgery. The above findings go a long way to explaining how the administration of BPC-157 is able to promote healthy tendon and ligament healing. Accelerates Bone Healing As gastrectomy is related to derogatory bone conditions such as osteoporosis it is no surprise that the use of BPC-157, with its well-known fracture and wound healing aspects, is associated with improved bone health. Research using rabbits has shown that the peptide is able to significantly improve healing related to osteoperiosteal bone defects over a six-week (1.5 months) period, especially following an autologous cortical graft or the local application of bone marrow. Furthermore, the number of animals that healed was much greater in the experimental than what occurred in the control group. So it seems that the use of BPC-157 can both increase the rate and the frequency of recovery from bone damage. Although the above experiments took place in lagomorphs the authors are very excited about its potential use in the management of bone-related impairments that may occur in human patients. Protects against intestinal damage One of the most exciting aspects of BPC-157 is its potential for protecting the intestines from inflammatory damage. When toxins were given to rats to mimic the effect of intestinal inflammation, the use of this peptide reduced the number of visual markers known to be associated with intestinal gut damage. The direct injections of BPC-157 into specific parts of rats is thought to help repair intestines through impacting nitric oxide signalling. It can also help to overcome problems related to short gut (Short Bowel Syndrome: SBS). This condition often leads to malnutrition and dehydration because of increased incidence of diarrhoea. The use of this peptide can help to make this problematic condition much better. It is also thought to be able to help repair damaged tissues caused by inflammatory bowel disease (IBD). Compulsion This peptide is known to impact dopamine levels, though there is as yet no evidence for the direct binding of dopamine receptors. It is therefore thought that its main action with regards to dopaminergic neurotransmission is likely to be through the antagonism of dopamine itself, and this interaction is thought to reduce the effects of amphetamine on compulsive behaviours. Protect against gut damage caused by NSAIDs Although they act great as painkillers one of the big problems with NSAIDs is that they can be toxic to the gut, this frequently leads to ulcers and an irritation of the bowels. BPC-157 is able to act as an anti-ulcer peptidergic agent and has been put forward as an NSAIDs antidote as it is beneficial against damage caused by mediated lesions in the gastrointestinal tract, brain, and the liver, and is able to counteract symptoms associated with the taking of aspirins, such as bleeding. The present research suggests that BPC-157 does not have toxic effects itself and is thus thought likely to have very high safety in its use against gastric damage caused by NSAIDs. Neuroprotection As BPC-157 is able to reduce cell damage in the hippocampus of rats it very likely confers neuroprotective effects. It can help protect the brain tissue from damage when rats are given cuprizone (a toxin that scientists use to mimic the effects of schizophrenia and multiple sclerosis) it is thought that actual protection of the nerves may actually occur through intestinal processes. WarningTHE GOODS OFFERED BY THE SELLER IS INTENDED FOR SCIENTIFIC AND DEVELOPMENT PURPOSES ONLY. The goods offered by the Seller include chemical substances that shall not be used as a drug, medicine, active substance, medical aid, cosmetic product, a substance for production of a cosmetic product neither for human consumption that is any food or food supplement or otherwise similarly used on humans or animals. References / Links Sever, M., et al. (2019). The stable gastric pentadecapeptide BPC 157 counteracts adjuvant arthritis in rats. Journal of Orthopaedic Research, 37(3), 582–593. PubMed Vukojević, J., et al. (2017). Stable gastric pentadecapeptide BPC 157 enhances the healing of transected rat Achilles tendon. Journal of Orthopaedic Research, 35(6), 1301–1310. PubMed Sikiric, P., et al. (2016). Stable gastric pentadecapeptide BPC 157 therapy for primary myotendinous junction transection, colitis, and intestinal anastomosis healing. World Journal of Gastroenterology, 22(26), 7373–7384. PubMed Central Sikiric, P., et al. (2018). BPC 157 and standard angiogenic growth factors. Vascular Pharmacology, 111, 57–65. PubMed Sikiric, P., et al. (2017). BPC 157 and the central nervous system. Current Neuropharmacology, 15(6), 857–865. PubMed Central

05

Product & matchup locker

Linked catalog and comparison files.

Comparison

Temperature Stability: Lyophilized vs Reconstituted BPC-157

BPC-157 exists in two forms with drastically different thermal stability profiles. Lyophilized (freeze-dried) powder is the stable storage form. Water has been removed under vacuu…